These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10870810)

  • 1. Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids).
    Siebenlist KR; Mosesson MW; Meh DA; DiOrio JP; Albrecht RM; Olson JD
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):293-304. PubMed ID: 10870810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
    Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
    Yilmazer M; Kurtay G; Sonmezer M; Akar N
    Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexisting dysfibrinogenemia (gamma Arg275His) and FV Leiden associated with thrombosis (Fibrinogen Crete).
    Travlou A; Gialeraki A; Merkouri E; Politou M; Sfyridaki A; Neerman-Arbez M
    Thromb Res; 2010 Aug; 126(2):e162-4. PubMed ID: 20546853
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
    Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legg-Calve-Perthes disease, venous and arterial thrombi, and the factor V Leiden mutation in a four-generation kindred.
    Glueck CJ; Tracy T; Wang P
    J Pediatr Orthop; 2007; 27(7):834-7. PubMed ID: 17878795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenteric vein thrombosis in a pregnant patient heterozygous for the factor V (1691 G --> A) Leiden mutation.
    Sönmezer M; Aytaç R; Demirel LC; Kurtay G
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):234-5. PubMed ID: 15140521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
    Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
    Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
    Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE
    Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.
    French JK; Van de Water NS; Sutton TM; Lund M; Gao W; McDowell J; Liu-Stratton Y; Pohorence J; Szymanski D; Goldschmidt-Clermont P; White HD; Browett PJ; Cooke G
    Am Heart J; 2003 Jan; 145(1):118-24. PubMed ID: 12514663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third trimester nonrecurrent fetal loss is associated with factor V Leiden and prothrombin gene mutations.
    Karateke A; Haliloglu B; Gurbuz A
    J Matern Fetal Neonatal Med; 2005 Nov; 18(5):299-304. PubMed ID: 16390788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
    Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
    Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of dysfibrinogenemia and thrombosis. Apropos of a family (Fibrinogen Melun) and review of the literature].
    Bentolila S; Samama MM; Conard J; Horellou MH; Ffrench P
    Ann Med Interne (Paris); 1995; 146(8):575-80. PubMed ID: 8734083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
    J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R255h amino acid substitution of protein Z identified in patients with factor V Leiden mutation.
    Kemkes-Matthes B; Matthes KJ; Souri M; Koseki-Kuno S; Ichinose A
    Br J Haematol; 2005 Jan; 128(2):248-52. PubMed ID: 15638861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural changes in the fibrin network of a pretoria family with dysfibrinogenemia: a scanning electron microscopical study.
    Pretorius E; Briedenhann S; Marx J; Franz RC
    Ultrastruct Pathol; 2006; 30(3):167-76. PubMed ID: 16825118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.